1.A cross-sectional study on the association of red cell distribution width and Acute Coronary Syndrome among patients admitted to the Bataan General Hospital and Medical Center
Monica B. Alagon ; Almalyn C. Sevilla
Philippine Journal of Internal Medicine 2024;62(1):262-266
		                        		
		                        			Introduction:
		                        			Red cell distribution width (RDW) is a parameter that is readily available as part of a standard complete blood
count (CBC). Studies have shown that an elevated RDW is associated with increased cardiovascular events including acute
coronary syndrome (ACS). This cross- sectional retrospective study was conducted to determine the association of RDW in
patients with ACS admitted to Bataan General Hospital and Medical Center (BGHMC).
		                        		
		                        			Methods:
		                        			A cross-sectional study was performed in a 500-bed tertiary care hospital in Bataan, Philippines. The clinical
medical records of patients with ACS were analyzed retrospectively. A total of 811 patients was admitted as cases of ACS
from January 2017 to December 2019. Using Slovin’s formula, the computed sample size was 261 patients. However, only
205 cases were included in the study in accordance to the eligibility criteria. The baseline RDW were recorded from the
CBC obtained upon admission of patients with ACS.
		                        		
		                        			Results:
		                        			Based on the data collected from January 2017 to December 2019 from patients admitted to BGHMC, there was
no significant association between RDW and in-house morbidity and mortality and classification of ACS.
		                        		
		                        			Conclusions
		                        			There were no significant association between RDW and in-house morbidity and mortality and classification
of ACS. The authors recommend to conduct the study for a longer duration to have more population included and to
include other parameters such as cardiac enzymes, electrocardiogram (ECG) changes and presence of co-morbidities.
		                        		
		                        		
		                        		
		                        			Erythrocyte Indices
		                        			;
		                        		
		                        			 Acute Coronary Syndrome
		                        			;
		                        		
		                        			 Angina, Unstable
		                        			;
		                        		
		                        			 ST Elevation Myocardial Infarction
		                        			
		                        		
		                        	
2.Characteristics of Silent Alpha Thalassemia Gene in Child-Bearing Adults in Guangdong.
Ge HUANG ; You-Wei ZHENG ; Ji WU ; Sheng-Nan LIU
Journal of Experimental Hematology 2023;31(6):1811-1814
		                        		
		                        			OBJECTIVE:
		                        			To investigate characteristics of silent alpha thalassemia genes in child-bearing adults in Guangdong, in order to provide data for the prevention and control of hemoglobin H disease.
		                        		
		                        			METHODS:
		                        			A total of 8 752 cases were collected from January 2016 to December 2020. Gap-PCR was used to detect the deletional of α-thalassemia mutations (-α3.7, -α4.2), while PCR reverse dot blot hybridization assay (RDB) was used to detect the non-deletional α-thalassemia mutations (Hb CS, Hb QS and Hb Westmead).
		                        		
		                        			RESULTS:
		                        			Among 8 752 subjects, 717 cases of silent α-thalassemia were detected, the detection rate was 8.19%, including 555 cases of deletional α-thalassemia (77.41%) and 162 cases of non-deletional α-thalassemia 22.59%. The mean corpuscular volume (MCV) of deletional silent α-thalassemia was (82.09±4.10) fl, and mean corpuscular hemoglobin (MCH) was (27.03±1.37) pg, which both were over the diagnostic cut-off value for thalassemia. The MCV of non-deletional silent α-thalassemia was (81.07±4.93) fl, and MCH was (26.77±2.20) pg. According to the diagnostic criteria, if using MCV<82 fl or (and) MCH<27 pg as a positive criteria for screening thalassemia in the childbearing age, the screening sensitivity was 53.14% and different in different genotype, among which ααQS/αα was 100%, -α3.7/αα, -α4.2/αα, ααCS/αα and ααWS/αα was 62.15%, 63.41%, 44.83% and 39.62%, respectively. Namely, nearly half the carriers of such mutations might have escaped detection as a result of their screening strategy.
		                        		
		                        			CONCLUSION
		                        			When a couple is preparing for pregnancy, if one of them has been determined to be mild α-thalassemia or hemoglobin H disease, other half is necessary to carry out silent α thalassemia detection to prevent the birth of children with hemoglobin H disease even if MCV>82 fl and MCH>27 pg.
		                        		
		                        		
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Pregnancy
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			alpha-Thalassemia/diagnosis*
		                        			;
		                        		
		                        			Genotype
		                        			;
		                        		
		                        			Mutation
		                        			;
		                        		
		                        			Erythrocyte Indices
		                        			;
		                        		
		                        			Polymerase Chain Reaction
		                        			;
		                        		
		                        			China
		                        			;
		                        		
		                        			beta-Thalassemia/genetics*
		                        			
		                        		
		                        	
3.Prognostic value of hemoglobin-to-red cell distribution width ratio in patients with cardiopulmonary resuscitation after out-of-hospital cardiac arrest.
Hong WANG ; Chao LAN ; Yao LUO ; Tangjuan ZHANG
Chinese Critical Care Medicine 2023;35(9):958-962
		                        		
		                        			OBJECTIVE:
		                        			To investigate the prognostic value of hemoglobin-to-red cell distribution width ratio (HRR) in patients with cardiopulmonary resuscitation (CPR) after out-of-hospital cardiac arrest (OHCA).
		                        		
		                        			METHODS:
		                        			A retrospective study was conducted. Patients aged ≥ 18 years with OHCA who were transferred to intensive care unit (ICU) after successful CPR from the emergency room of the First Affiliated Hospital of Zhengzhou University from August 2016 to February 2022 were enrolled. General clinical data, initial vital signs, acute physiology and chronic health evaluation II (APACHE II), Glasgow coma scale (GCS), first laboratory indicators after admission to ICU [including white blood cell count (WBC), red blood cell count (RBC), hemoglobin (Hb), pH value, lactic acid (Lac), 6-hour lactic acid clearance (LCR), red cell distribution width (RDW), HRR], length of ICU stay were collected. According to whether the patients died in hospital, the patients were divided into survival group and death group. Binary Logistic regression was used to analyze the independent factors influencing the prognosis of patients after CPR. Receiver operator characteristic curve (ROC curve) was drawn to analyze the predictive value of independent influencing factors for the prognosis of patients after CPR.
		                        		
		                        			RESULTS:
		                        			A total of 122 patients were enrolled after OHCA CPR, of which 88 died in hospital, the in-hospital mortality was 72.13%. There were no significant differences in age, past medical history, initial vital signs and WBC in ICU between the two groups. Compared with the death group, the survival group had higher GCS score, RBC, Hb, pH value, 6-hour LCR, HRR, lower APACHE II score, Lac, RDW level, and longer length of ICU stay. Multivariate Logistic regression analysis showed that APACHE II score, GCS score, 6-hour LCR, HRR, length of ICU stay were independent factors influencing the prognosis of patients after CPR [APACHE II score: odds ratio (OR) = 0.784, 95% confidence interval (95%CI) was 0.683-0.901, P = 0.001; GCS score: OR = 1.390, 95%CI was 1.059-1.823, P = 0.018; 6-hour LCR: OR = 1.039, 95%CI was 1.015-1.064, P = 0.001; HRR: OR = 2.047, 95%CI was 1.383-3.029, P < 0.001; length of ICU stay: OR = 1.128, 95%CI was 1.046-1.216, P = 0.002]. ROC curve analysis showed that HRR, 6-hour LCR and APACHE II score could predict the prognosis of patients after CPR. The sensitivity was 85.3% and the specificity was 54.5% when the area under the ROC curve (AUC) of HRR was 0.731, and the cut-off value was 8.555. The sensitivity was 88.2% and the specificity was 46.6%, when the AUC of 6-hour LCR was 0.701, and the cut-off value was 28.947%. The sensitivity was 73.9% and the specificity was 79.4% when the AUC of APACHE II score was 0.848, the cut-off value was 22.000. The predictive value of the combination of HRR and 6-hour LCR was higher than that of a single index. The sensitivity was 79.3% and the specificity was 76.1%, when the AUC was 0.796, the cut-off value was 0.296.
		                        		
		                        			CONCLUSIONS
		                        			HRR, 6-hour LCR and APACHE II score have high prognostic value in patients with OHCA after CPR. HRR < 8.555, 6-hour LCR < 28.947% and APACHE II score > 22.000 indicated poor prognosis.
		                        		
		                        		
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Erythrocyte Indices
		                        			;
		                        		
		                        			Prognosis
		                        			;
		                        		
		                        			Retrospective Studies
		                        			;
		                        		
		                        			Out-of-Hospital Cardiac Arrest/therapy*
		                        			;
		                        		
		                        			ROC Curve
		                        			;
		                        		
		                        			Intensive Care Units
		                        			;
		                        		
		                        			Hemoglobins
		                        			;
		                        		
		                        			Lactic Acid
		                        			;
		                        		
		                        			Cardiopulmonary Resuscitation
		                        			;
		                        		
		                        			Sepsis/diagnosis*
		                        			
		                        		
		                        	
4.Red cell distribution width and its association with Neonatal Bacteremia: A case-control study
Hashima P. Diamla ; Robert Dennis J. Garcia
Pediatric Infectious Disease Society of the Philippines Journal 2022;23(1):50-61
		                        		
		                        			Background:
		                        			Bacteremia is a major cause of prolonged hospital stay and mortality in neonates and its early diagnosis remains a challenge to pediatricians. Red cell distribution width (RDW) is a component of a complete blood count test which is accessible and inexpensive and has been reported to be a possible diagnostic marker for neonatal bacteremia. This study determined the association of RDW with neonatal bacteremia in term and preterm neonates.
		                        		
		                        			Methodology:
		                        			This is a retrospective case-control study of 26 bacteremic neonates as cases and 104 non-bacteremic neonates, either symptomatic or with risk factors for bacteremia, as controls. Included newborns were seen between January 1, 2010 to September 30, 2021. Laboratory data obtained were CBC, C-reactive protein and blood culture.
		                        		
		                        			Results:
		                        			RDW values between bacteremic and non-bacteremic neonates were not significantly different. There was an association between RDW and neonatal bacteremia at an RDW level of > 16.1, where the likelihood of bacteremia was three times higher compared with lower RDW values. Significantly lower levels of hemoglobin, hematocrit, RBC count, WBC count, platelet count, MCH and MCHC, and a higher CRP level were seen among bacteremic neonates compared to those who were not. The median RDW for both term and preterm neonates was close to 16, with a narrow inter-quartile range at 1 and 2 for controls and cases, respectively. The range (minimum to maximum) of RDW values of bacteremic preterm neonates was more variable than those of term neonates. Using RDW to detect bacteremia, it had an equivocal discriminatory power or AUC of 0.6056. We found insufficient evidence to demonstrate a correlation between RDW and other CBC parameters, except for MCHC. For MCHC, the results suggest a very weak and indirect correlation.
		                        		
		                        			Conclusion
		                        			RDW was not significantly different between bacteremic and non-bacteremic neonates, but there was a suggested association between RDW and bacteremia at an RDW level of > 16.1, at which level there was a 3-fold risk for bacteremia.
		                        		
		                        		
		                        		
		                        			Erythrocyte Indices
		                        			;
		                        		
		                        			 Case-Control Studies
		                        			
		                        		
		                        	
5.Influence of the Ratio of Peripheral Hemoglobin-to-Red Cell Distribution width on the Prognosis of Patients with Diffuse Large B-cell Lymphoma.
Xue-Yan DONG ; Guo-Feng TANG ; Wei CHEN ; Jiang CAO ; Hai CHENG ; Zhen-Yu LI ; Kai-Lin XU
Journal of Experimental Hematology 2022;30(3):765-770
		                        		
		                        			OBJECTIVE:
		                        			To investigate the influence of peripheral hemoglobin (Hb)-to-red cell distribution width (RDW) ratio (HRR) on the prognosis of patients with diffuse large B-cell lymphoma (DLBCL).
		                        		
		                        			METHODS:
		                        			Data of 265 patients with diffuse large B-cell lymphoma (DLBCL) at the Affiliated Hospital of Xuzhou Medical University from January 2014 to December 2019 were retrospectively analyzed. 132 healthy people in the same period were used as normal control group. The best cut-off points of HRR was determined by receiver operating characteristics (ROC) curve; the chi-square test was used to analyze the correlation of clinical characteristics with HRR; the Kaplan-Meier method was used to compare the overall survival (OS) and progression-free survival (PFS) of HRR patients in different groups; the Cox proportional risk model was used for univariate and multivariate analysis.
		                        		
		                        			RESULTS:
		                        			The best cut-off value of HRR was 0.936, which was divided into low HRR group and high HRR group. The low HRR group had a higher ECOG score, higher incidence of advanced Ann Arbor stage, higher NCCN-IPI score, and elevated LDH level. K-M survival analysis showed that OS (P<0.001) and PFS (P<0.001) in the low HRR group were significantly shorter than that in the higher HRR group. The multivariate analysis revealed that HRR was an independent predictor of OS(HR=0.379,95%CI:0.237-0.605,P<0.001) and PFS (HR=0.384,95%CI:0.241-0.614,P<0.001) in DLBCL patients.
		                        		
		                        			CONCLUSION
		                        			Low HRR(<0.936) in patients with DLBCL indicates a poor prognosis, which is an independent prognosis risk factor.
		                        		
		                        		
		                        		
		                        			Erythrocyte Indices
		                        			;
		                        		
		                        			Hemoglobins
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Lymphoma, Large B-Cell, Diffuse/pathology*
		                        			;
		                        		
		                        			Prognosis
		                        			;
		                        		
		                        			Retrospective Studies
		                        			
		                        		
		                        	
6.Hematological Characteristics of Different Genotypes of Thalassemia among Reproductive Population in Chongqing.
Si-Yue LI ; Qiu-Hong LI ; Si-Wei YI ; Chun-Li LI
Journal of Experimental Hematology 2022;30(1):211-216
		                        		
		                        			OBJECTIVE:
		                        			To investigate the hematological characteristics and genotype distribution of thalassemia among people at reproductive age in Chongqing.
		                        		
		                        			METHODS:
		                        			Hematology analysis and capillary electrophoresis were performed in 29 145 participants at reproductive age. The patients with positive results were confirmed by thalassemia genotyping. Genotype distribution and characteristics of mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH) and hba2 levels in thalassemia patients were analyzed.
		                        		
		                        			RESULTS:
		                        			--SEA/αα (45.10%), -α3.7/αα (39.31%) and -α4.2/αα (8.46%) were the most common genotypes of α-thalassemia, while CD17 (HBB: c. 52A>T) (31.67%), CD41-42 (HBB: c. 126-129 del TTCT) (26.87%) and IVS-Ⅱ-654 (HBB: c. 316-197 C>T) (24.21%) were the most common genotypes of β-thalassemia in Chongqing. In α-thalassemia ααCS/αα showed the lowest hba2 value (2.18±0.23)%, while --SEA/αα showed the lowest MCV (71.9±8.5) fl and MCH (22.7±3.3) pg value. The patients in βE (HBB: c. 79G>A) group showed comparatively higher values of MCV and MCH and significantly lower HbA and hba2 values than the other genotypes. There was no significant difference in HbA, hba2, MCV, MCH levels of the patients between pregnant group and non-pregnant group.
		                        		
		                        			CONCLUSIONS
		                        			In Chongqing, there are differences in hematological characteristics among patients with different thalassemia genotypes. There is no significant effect of pregnancy on HbA, hba2, MCV and MCH has been found.
		                        		
		                        		
		                        		
		                        			China
		                        			;
		                        		
		                        			Erythrocyte Indices
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Genotype
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Mutation
		                        			;
		                        		
		                        			Pregnancy
		                        			;
		                        		
		                        			alpha-Thalassemia/genetics*
		                        			;
		                        		
		                        			beta-Thalassemia
		                        			
		                        		
		                        	
7.The Relationship between Hematopoietic Scoring System Composed of HB,PLT and MCV and Prognosis and Curative Effect of Multiple Myeloma Patients.
Li-Min SONG ; Yan-Ping MA ; Ru XUE ; Lu CHENG
Journal of Experimental Hematology 2022;30(2):481-486
		                        		
		                        			OBJECTIVE:
		                        			To investigate the prognostic value of hemopoietic scoring system composed of hemoglobin (HB), platelet count (PLT) and mean corpuscular volume (MCV) in MM patients and its correlation with curative effect.
		                        		
		                        			METHODS:
		                        			The clinical data of 172 newly diagnosed MM patients treated by bortezomib as the first-line regimen in our hospital from May 2014 to December 2019 were collected, three variables (HB≤100 g/L, PLT≤150×109/L, MCV≥96 fl) were introduced, each variable was distributed 1 score, the patients were divided into four groups (0, 1, 2 and 3 points in group 1, 2, 3 and 4, respectively), and the clinical characteristics and prognosis of the patients in the four groups were analyzed. The initial efficacy evaluation after 3-4 courses of treatment was carried out, and the curative effect of the patients in the different hematopoiesis score groups were compared.
		                        		
		                        			RESULTS:
		                        			The median OS time of the patients in group 1, 2, 3 and 4 was 27.0, 22.5, 20.7 and 18.1 months, while the median PFS time were 23.0, 19.0, 18.0 and 14.0 months, respectively. The OS and PFS of the patients in low score group were significantly better than those in high score group (P=0.045, P=0.048). There was no significant difference in the curative effect of the patients treated by bortezomib after 3-4 courses (P>0.05).
		                        		
		                        			CONCLUSION
		                        			Hematopoiesis score can preliminarily predict the overall survival of newly diagnosed MM patients, but there is no significant difference between different scoring groups in the initial curative effect.
		                        		
		                        		
		                        		
		                        			Bortezomib/therapeutic use*
		                        			;
		                        		
		                        			Erythrocyte Indices
		                        			;
		                        		
		                        			Hemoglobins/therapeutic use*
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Multiple Myeloma/diagnosis*
		                        			;
		                        		
		                        			Prognosis
		                        			;
		                        		
		                        			Retrospective Studies
		                        			
		                        		
		                        	
8.Iron deficiency and early childhood caries: a systematic review and meta-analysis.
Shuai-Qi JI ; Rui HAN ; Ping-Ping HUANG ; Shuang-Yi WANG ; Hao LIN ; Lei MA
Chinese Medical Journal 2021;134(23):2832-2837
		                        		
		                        			BACKGROUNDS:
		                        			Previous surveys have found that children with iron deficiency (ID) were likely to suffer from early childhood caries (ECC). We aimed to assess the scientific evidence about whether ID is intrinsically related to ECC.
		                        		
		                        			METHODS:
		                        			The medical subject headings (MeSH) terms and free words were searched on PubMed, Web of Science, Cochrane, China National Knowledge Infrastructure, Wanfang, and the Database for Chinese Technical Periodicals from March 2020 to September 2020. Two researchers independently screened the articles. Data extraction and cross-checking were performed for the studies that met the inclusion criteria. Meta-analysis was performed using the Cochrane Collaboration's Review Manager 5.3 software.
		                        		
		                        			RESULTS:
		                        			After excluding duplication and irrelevant literature, 12 case-control studies were included in the study. The meta-analysis demonstrated that children with ECC were more likely to have ID (odds ratio [OR] = 2.63, 95% confidence interval [CI]: [1.85, 3.73], P < 0.001). There was no statistically significant association found between the level of serum ferritin and ECC (weighted mean difference (WMD) = -5.80, 95% CI: [-11.97, 0.37], P = 0.07). Children with ECC were more likely to have iron-deficiency anemia (OR = 2.74, 95% CI: [2.41,3.11], P < 0.001). The hemoglobin (HGB) levels in the ECC group were significantly lower compared with that in the ECC-free group (WMD = -9.96, 95% CI: [-15.45, -4.46], P = 0.0004). The mean corpuscular volume (MCV) levels in the ECC group were significantly lower compared with that in the ECC-free group (WMD = -3.72, 95% CI: [-6.65, -0.79], P = 0.01).
		                        		
		                        			CONCLUSIONS
		                        			ID was more prevalent in children with ECC, and the markers of iron status in the ECC group, such as serum ferritin, HGB, and MCV, were relatively lower than the ECC-free group.
		                        		
		                        		
		                        		
		                        			Anemia, Iron-Deficiency/epidemiology*
		                        			;
		                        		
		                        			Case-Control Studies
		                        			;
		                        		
		                        			Child
		                        			;
		                        		
		                        			Child, Preschool
		                        			;
		                        		
		                        			Dental Caries Susceptibility
		                        			;
		                        		
		                        			Erythrocyte Indices
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Iron Deficiencies
		                        			
		                        		
		                        	
9.Effectiveness of Using Mean Corpuscular Volume and Mean Corpuscular Hemoglobin for Beta-thalassemia Carrier Screening in the Guangdong Population of China.
Heng GU ; Yong Xia WANG ; Meng Xuan DU ; Shan Shan XU ; Bing Yi ZHOU ; Ming Zhen LI
Biomedical and Environmental Sciences 2021;34(8):667-671
		                        		
		                        			
		                        			Beta (β)-thalassemia is one of the most common hemoglobinopathies worldwide, creating major public health problems and social burdens in many regions. Screening for β-thalassemia carriers is crucial for controlling this condition. To investigate the effectiveness of mean corpuscular volume (MCV) and mean corpuscular hemoglobin (MCH) for screening β-thalassemia, retrospective data were analyzed for 6,779 β-thalassemia carriers subjected to genetic testing following thalassemia screening in Guangdong province between January 2018 and December 2019. Prevalent mutations observed included CD41/42 (-TTCT) (38.43%), IVS-II-654 (C > T) (25.71%), -28 (A > G) (15.78%), CD17 (AAG > TAG) (10.03%), and β
		                        		
		                        		
		                        		
		                        			Adult
		                        			;
		                        		
		                        			China
		                        			;
		                        		
		                        			Erythrocyte Indices
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Mass Screening
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Mutation
		                        			;
		                        		
		                        			Young Adult
		                        			;
		                        		
		                        			beta-Thalassemia/genetics*
		                        			
		                        		
		                        	
10.The Value of Umbilical Cord Blood Erythrocyte Index in the Screening of Neonatal Thalassemia.
Chou-Ju ZHUANG ; Xue-Wei WU ; Zhi-Dan WAN ; Xiang HUANG
Journal of Experimental Hematology 2021;29(1):193-197
		                        		
		                        			OBJECTIVE:
		                        			To investigate the relationship between umbilical cord blood erythrocyte index and thalasse-mia, and reveal its clinical value in the screening of thalassemia in neonates.
		                        		
		                        			METHODS:
		                        			2 919 cases of umbilical cord blood from neonatal who were born in Boai Hospital of Zhongshan Affiliated with Southern Medical University from July 2017 to December 2018 were collected, the routine blood tests were preformed to detect the umbilical cord blood. Thalassemia gene in peripheral blood of neonates was collected. The cut-off values of cord blood indexes were determined, and the sensitivity, specificity and other evaluation indexs were calculated.
		                        		
		                        			RESULTS:
		                        			Among the cord blood in 2 919 neonates, 314 cases were detected out as thalassemia(positive rate: 10.76%). The average level of RBC and RDW in 2 605 children with non-thalassemia was lower than those with 314 children with thalassemia. The levels of Hb, MCV, MCH, MCHC, HCT, Hb/RBC and MCV/RBC in children with non-thalassemia were higher than those with thalassemia, and there were significant differences in the neonates between the two groups. The RBC and RDW levels of neonates in the α-thalassemia group were higher than those in the non-thalassemia group, while the levels of Hb, MCV, MCH, MCHC, HCT, Hb/RBC and MCV/RBC of neonates were lower than those in the non-thalassemia group. The levels of MCV, MCH and Hb/RBC of neonates in the β-thalassaemia group were lower than those in the non-thalassaemia group. The levels of MCV, MCH, Hb/RBC, and MCV/RBC of neonates in the complex thalassemia group were lower than those in the non-thalassemia group. When the cut-off value of MCV was set to 106.05 fl, the sensitivity was 0.548, and the specificity was 0.907, the specificity was the highest among all indexes. The area under the ROC curve of the combined diagnosis of MCH+MCV/RBC was the largest(0.807), the sensitivity was 0.710, the specificity was 0.841, the positive predictive value was 0.348, and the negative predictive value was 0.960.
		                        		
		                        			CONCLUSION
		                        			The single indicator of umbilical cord blood red blood cells has advantages and disadvantages for the screening of thalassemia, but the combination of MCH+MCV/RBC can improve the accuracy of the screening or diagnosis of thalassemia, it also has a positive effect to the reduction of the birth rate of children with thalassemia major, which showed a high popularization value in primary hospitals.
		                        		
		                        		
		                        		
		                        			Child
		                        			;
		                        		
		                        			Erythrocyte Indices
		                        			;
		                        		
		                        			Fetal Blood
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Infant, Newborn
		                        			;
		                        		
		                        			Mass Screening
		                        			;
		                        		
		                        			alpha-Thalassemia/diagnosis*
		                        			;
		                        		
		                        			beta-Thalassemia
		                        			
		                        		
		                        	
            

Result Analysis
Print
Save
E-mail